Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Mike_Cloonan
|
| gptkbp:developedBy |
small molecule modulators for CFTR protein
|
| gptkbp:focusesOn |
cystic fibrosis therapies
|
| gptkbp:foundedYear |
2019
|
| gptkbp:founder |
gptkb:Mike_Cloonan
|
| gptkbp:fundedBy |
gptkb:Omega_Funds
gptkb:RA_Capital_Management gptkb:F-Prime_Capital gptkb:Tango_Capital gptkb:Tectonic_Ventures |
| gptkbp:headquartersLocation |
gptkb:Boston,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sionna Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:website |
https://sionnatherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Mark_Leschly
|
| gptkbp:bfsLayer |
6
|